| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medicine, Gene Therapy Program, Louisiana State University Health Sciences Center, New Orleans, LA 70112;
Department of Rheumatology, Rheumatology Research and Advanced Therapeutics, Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands; and
Amgen Washington, Seattle, WA 98101.
IL-17 is a proinflammatory cytokine suspected to be involved in inflammatory and autoimmune diseases such as rheumatoid arthritis. In the present study, we report that IL-17R signaling is required in radiation-resistant cells in the joint for full progression of chronic synovitis and bone erosion. Repeated injections of Gram-positive bacterial cell wall fragments (streptococcal cell wall) directly into the knee joint of naive IL-17R-deficient (IL-17R–/–) mice had no effect on the acute phase of arthritis but prevented progression to chronic destructive synovitis as was noted in wild-type (wt) mice. Microarray analysis revealed significant down-regulation of leukocyte-specific chemokines, selectins, cytokines, and collagenase-3 in the synovium of IL-17R–/– mice. Bone marrow (BM) chimeric mice revealed the need for IL-17R expression on radiation-resistant joint cells for destructive inflammation. Chimeric mice of host wt and donor IL-17R–/– BM cells developed destructive synovitis in this chronic reactivated streptococcal cell wall arthritis model similar to wt
wt chimeras. In contrast, chimeric mice of host IL-17R–/– and donor wt BM cells were protected from chronic destructive arthritis similar as IL-17R–/–IL-17R–/– chimeras. These data strongly indicate that IL-17R signaling in radiation-resistant cells in the joint is required for turning an acute macrophage-mediated inflammation into a chronic destructive synovitis.
This article has been cited by other articles:
|
|
 |
|
  D. He, L. Wu, H. K. Kim, H. Li, C. A. Elmets, and H. Xu IL-17 and IFN-{gamma} Mediate the Elicitation of Contact Hypersensitivity Responses by Different Mechanisms and Both Are Required for Optimal Responses J. Immunol., July 15, 2009; 183(2): 1463 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gonzalez-Garcia, Y. Zhao, S. Ju, Q. Gu, L. Liu, J. K. Kolls, and B. Lu IL-17 Signaling-Independent Central Nervous System Autoimmunity Is Negatively Regulated by TGF-{beta} J. Immunol., March 1, 2009; 182(5): 2665 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chizzolini, R. Chicheportiche, M. Alvarez, C. de Rham, P. Roux-Lombard, S. Ferrari-Lacraz, and J.-M. Dayer Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion Blood, November 1, 2008; 112(9): 3696 - 3703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Smith, M. A. Stark, A. Zarbock, T. L. Burcin, A. C. Bruce, D. Vaswani, P. Foley, and K. Ley IL-17A Inhibits the Expansion of IL-17A-Producing T Cells in Mice through "Short-Loop" Inhibition via IL-17 Receptor J. Immunol., July 15, 2008; 181(2): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, M. M. Nooh, M. Kotb, and F. Re Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production J. Leukoc. Biol., February 1, 2008; 83(2): 409 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B van den Berg, P. L van Lent, L. A B Joosten, S. Abdollahi-Roodsaz, and M. I Koenders Amplifying elements of arthritis and joint destruction Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii45 - iii48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schnyder-Candrian, D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder Interleukin-17 is a negative regulator of established allergic asthma J. Exp. Med., November 27, 2006; 203(12): 2715 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Toy, D. Kugler, M. Wolfson, T. V. Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex J. Immunol., July 1, 2006; 177(1): 36 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Koenders, E. Lubberts, F. A. J. van de Loo, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, J. K. Kolls, F. E. Di Padova, L. A. B. Joosten, and W. B. van den Berg Interleukin-17 Acts Independently of TNF-{alpha} under Arthritic Conditions J. Immunol., May 15, 2006; 176(10): 6262 - 6269. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
